Earnings
AIM
2.100
-0.47%
-0.010
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
38.50M
501.00K
--
1.12M
--
--
0.00
--
--
--
184.00K
--
40.31M
6.65M
--
15.38M
--
--
1.50M
--
748.00K
24.27M
64.58M
--
383.00K
0.00
--
--
--
--
--
489.00K
--
--
--
--
1.10M
1.88M
--
--
--
312.00K
2.19M
3.29M
42.00K
402.54M
-341.97M
--
--
--
61.29M
61.29M
64.58M
FY 2019-12-31
1.47M
7.31M
--
820.00K
--
--
0.00
--
--
--
848.00K
--
10.45M
7.27M
--
--
--
--
1.15M
--
1.89M
10.31M
20.75M
--
472.00K
0.00
--
--
--
--
--
441.00K
--
--
--
--
1.13M
6.01M
--
--
--
171.00K
6.18M
7.31M
10.00K
340.23M
-327.57M
--
--
--
13.44M
13.44M
20.75M
FY 2018-12-31
299.00K
1.53M
--
1.09M
--
--
0.00
--
--
--
880.00K
0.00
3.80M
7.78M
--
--
--
--
912.00K
--
1.35M
10.05M
13.85M
--
680.00K
3.41M
--
--
--
--
--
1.00M
--
--
--
--
5.29M
2.32M
--
--
--
1.06M
3.38M
8.67M
49.00K
323.70M
-318.57M
--
--
--
5.17M
5.17M
13.85M
FY 2017-12-31
1.41M
695.00K
--
24.00K
--
--
0.00
--
--
--
610.00K
764.00K
3.50M
8.59M
--
--
--
--
858.00K
--
1.26M
10.70M
14.21M
--
741.00K
0.00
--
--
--
--
--
1.97M
--
--
--
--
2.71M
1.83M
--
--
--
962.00K
2.80M
5.50M
33.00K
317.42M
-308.76M
--
--
--
8.70M
8.70M
14.21M
FY 2016-12-31
2.41M
3.46M
--
--
--
--
0.00
--
0.00
--
309.00K
764.00K
6.94M
9.51M
--
--
--
--
872.00K
--
1.55M
11.93M
18.87M
--
887.00K
0.00
--
--
--
--
--
1.55M
--
--
--
--
2.44M
0.00
--
--
--
940.00K
940.00K
3.38M
24.00K
315.98M
-300.50M
--
--
--
15.50M
15.50M
18.87M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out AIM latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze AIM ImmunoTech Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.